Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer
S. Rao, D. Cunningham, R. E. Hawkins, M. E. Hill, D. Smith, F. Daniel, P. J. Ross, J. Oates, A. R. Norman
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer'. Together they form a unique fingerprint.